2023 Marketing Portfolios 
The Dermatology Digest
SEPTEMBER 30, 2024
market, is an important milestone on our pathway to consistently broadening our biopharma portfolio in the U.S. In February 2023, Fresenius Kabi and Formycon entered into a global commercialization partnership for the ustekinumab biosimilar candidate covering key global markets. and worldwide.
The Dermatology Digest
MARCH 27, 2024
Alexis (Lexi) Stern is Merz Aesthetics’ new Chief Marketing Officer. Stern will join the global leadership team and will be responsible for leading the portfolio and brand strategies. Stern served as Senior Vice President of Global Marketing at Covergirl, Coty Inc.’s Most recently, Ms.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Aesthetics Advisor
SEPTEMBER 15, 2023
Moreover, Glenmark Pharmaceuticals received manufacturing and marketing approval for the Nitric Oxide Nasal Spray (NONS) as part of an accelerated approval process. This is clinically relevant for the use of Carragelose-containing products: The marketed nasal sprays have a Carragelose concentration of 1.2 the South-African or B.1.351,
Spa Executive
NOVEMBER 10, 2023
As global vice president of wellbeing, she will develop and deepen the wellness experience across Auberge Resorts Collection’s portfolio. Under the mentorship of Susan Harmsworth, she honed her skills in areas like spa therapies, aromatherapy, wellness operations, design, marketing, and public relations.
The Dermatology Digest
DECEMBER 21, 2023
“We are increasingly optimistic about the near-term potential that the next-generation technology in the Evolysse and Estyme fillers lines will offer customers in the fast-growing facial HA market. As such, we have agreed to receive payment for the license for the European markets in the form of Evolus’ common shares.
The Dermatology Digest
DECEMBER 21, 2023
“We are increasingly optimistic about the near-term potential that the next-generation technology in the Evolysse and Estyme fillers lines will offer customers in the fast-growing facial HA market. As such, we have agreed to receive payment for the license for the European markets in the form of Evolus’ common shares.
The Eco Well Blog
MAY 8, 2023
He also holds executive business certifications in bargaining, negotiations and strategic finance and marketing from The Darden and Wharton Business Schools and is a member of the Society of Toxicology, Photodermatology Society and Society for Investigative Dermatology. Carl presented at the Sunscreen E-Summit on behalf of DSM.
Expert insights. Personalized for you.
36 
Let's personalize your content